Novo Nordisk wins Dutch court injunction in semaglutide patent infringement case

Danish ​drugmaker Novo ‌Nordisk said on ​Wednesday ​it had won ⁠a ​preliminary injunction ​against Ceban Ziekenhuisfarmacie B.V. ​from ​a district court ‌in ⁠the Netherlands in a ​patent ​infringement...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。